In the News
GenomeWeb - January 6, 2021
TwinStrand Biosciences Explores Error Reduction Sequencing Tech in Various Applications
Since the commercial launch of its technology last year, the firm has been working on validating it in various research studies in partnership with academic groups and pharmaceutical companies, Salk said, and is in the midst of branching out into new application areas.
X
TwinStrand Biosciences Explores Error Reduction Sequencing Tech in Various Applications
GenomeWeb - January 6, 2021
TwinStrand Biosciences Explores Error Reduction Sequencing Tech in Various Applications
PRNewswire - January 6, 2021
TwinStrand Biosciences Appoints Dr. Gary Gilliland to Board of Directors
PRNewswire - November 18, 2020
TwinStrand Biosciences Licenses Duplex Sequencing Technology to Foundation Medicine
Puget Sound Business Journal - October 1, 2020
40 Under 40: Jesse Salk diagnoses cancer using DNA sequencing and treats the disease as a practicing oncologist
GEN - August 1, 2020
Liquid Biopsies Generate Ample Insights from Sparse Clues
Gene Online - July 20, 2020
The Profound Impact of Duplex Sequencing: An Interview with Jesse Salk, CEO, TwinStrand Biosciences
Bio-IT World - July 15, 2020
In The Midst Of A Pandemic, Duplex Sequencing Comes Of Age
Timmerman Report - June 15, 2020
Timmerman Report- DNA Sequencing Startups Aim to Reduce Cost, Increase Meaning in the Data
GEN - April 1, 2020
Sequencing’s Stars Urge Exploration of New Dimensions
GEN - March 1, 2020
Genomic Medicine Identifies Reconcilable Differences
DeciBio - February 27, 2020
AGBT 2020: DeciBio Highlights – Spatial Profiling Reloaded & MGI Unleashed 2
PRNewswire - February 25, 2020
TwinStrand Biosciences Launches Duplex Sequencing Technology
LinkedIn - January 7, 2020
Leveraging big data to improve genome sequencing accuracy by 10,000x
